Manulife (Manufacturers Life Insurance)’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,455
| Closed | -$244K | – | 3024 |
|
|
2024
Q4 | $244K | Sell |
25,455
-1,818
| -7% | -$17.5K | ﹤0.01% | 2534 |
|
|
2024
Q3 | $78K | Sell |
27,273
-1,247
| -4% | -$3.57K | ﹤0.01% | 2921 |
|
|
2024
Q2 | $83.3K | Buy |
28,520
+3,552
| +14% | +$10.4K | ﹤0.01% | 2869 |
|
|
2024
Q1 | $79.6K | Sell |
24,968
-3,065
| -11% | -$9.78K | ﹤0.01% | 2829 |
|
|
2023
Q4 | $94.2K | Sell |
28,033
-2,363
| -8% | -$7.94K | ﹤0.01% | 2835 |
|
|
2023
Q3 | $72.3K | Hold |
30,396
| – | – | ﹤0.01% | 2892 |
|
|
2023
Q2 | $53.5K | Buy |
+30,396
| New | +$53.5K | ﹤0.01% | 2946 |
|
|
2022
Q2 | – | Sell |
-14,614
| Closed | -$65.5K | – | 3171 |
|
|
2022
Q1 | $65.5K | Buy |
+14,614
| New | +$65.5K | ﹤0.01% | 3016 |
|
|
2021
Q3 | – | Sell |
-19,599
| Closed | -$196K | – | 3235 |
|
|
2021
Q2 | $196K | Sell |
19,599
-664
| -3% | -$6.64K | ﹤0.01% | 3121 |
|
|
2021
Q1 | $194K | Buy |
+20,263
| New | +$194K | ﹤0.01% | 2903 |
|